—

Medacta Group SA (MOVE.SW) — the peer cohort

As of 2026-10-08 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Medacta Group SA ranks 6 of 8 in its cohort on the Closelooknet composite (48/100) — the cohort is led by BB Biotech AG at 73/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
MOVE.SW Medacta Group SA 48 10 58 33 warn 36.6%
DXCM DexCom Inc 66 83 80 37 watch 9%
GMED Globus Medical 59 26 65 59 bear 27.3%
SNN Smith & Nephew SNATS Inc 56 21 57 74 warn 27%
SOON.SW Sonova H Ag 56 90 73 52 neutral 2.4%
GKOS Glaukos Corp 48 76 23 18 info 15.8%
SHL.DE Siemens Healthineers AG 48 50 49 57 bull 20.6%
BION.SW BB Biotech AG 73 57 96 81 info 16.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-08

Quick answers

Who are Medacta Group SA's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: DexCom Inc (DXCM), Globus Medical (GMED), Smith & Nephew SNATS Inc (SNN), Sonova H Ag (SOON.SW), Glaukos Corp (GKOS), Siemens Healthineers AG (SHL.DE), BB Biotech AG (BION.SW).

How does MOVE.SW score against its peers?

Medacta Group SA's composite reads 48/100, ranking 6 of 8 in its cohort as of 2026-10-08; the cohort's highest composite is BB Biotech AG at 73/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.